Literature DB >> 8105771

Genetic and infectious prion diseases.

S B Prusiner1.   

Abstract

Enriching fractions from Syrian hamster (SHa) brain for scrapie prion infectivity led to the discovery of the prion protein (PrP). Prion diseases include scrapie of sheep and bovine spongiform encephalopathy of cattle as well as Creutzfeldt-Jakob disease (CJD) and Gerstmann-Sträussler-Scheinker syndrome (GSS) of humans. Transgenic (Tg) mice expressing both SHa and mouse (Mo) PrP genes were used to probe the molecular basis of the species barrier and the mechanism of scrapie prion replication. Bioassays of brain extracts from two scrapie-infected Tg lines showed that the prion inoculum determines that prions are synthesized de novo, even though the cells express both PrP genes. Studies with artificial prions produced from chimeric Mo/SHaPrP transgenes underscore the concept that inoculated prion dictates which prion will be replicated. Discovery of mutations in the PrP genes of humans with GSS and familial CJD established that prion diseases are both genetic and infectious. Transgenic mice expressing high levels of MoPrP-P101L, corresponding to the GSS point mutation (P102L) in human PrP, spontaneously develop neurologic dysfunction, spongiform degeneration, and astrocytic gliosis. Inoculation of brain extracts prepared from these Tg (MoPrP-P101L) mice produced neurodegeneration in recipient animals after prolonged incubation times. These results are in accord with those of other studies and argue that prions are devoid of foreign nucleic acid. Structural investigations of cellular prion protein (PrPC) and prion protein scrapie (PrPSc) suggest that the difference may be conformational. Conditions that diminished the beta-sheet content of PrPSc were the same as those identified previously that inactivate prion infectivity. Whether prion diversity as reflected by distinct "strains" producing different patterns of PrPSc accumulation is due to different conformers of PrPSc remains to be established. Advances in the purification and characterization of both PrPC and PrPSc seem to have identified the central event in PrPSc synthesis and prion propagation, ie, the unfolding of PrPC followed by its refolding into PrPSc. These findings underscore the fundamental features of prion structure and propagation that differentiate prions from other transmissible pathogens.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8105771     DOI: 10.1001/archneur.1993.00540110011002

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  28 in total

1.  Intercellular transfer of a glycosylphosphatidylinositol (GPI)-linked protein: release and uptake of CD4-GPI from recombinant adeno-associated virus-transduced HeLa cells.

Authors:  S M Anderson; G Yu; M Giattina; J L Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Creutzfeldt-Jakob disease and infection control.

Authors:  L Johnston; J Conly
Journal:  Can J Infect Dis       Date:  2001-11

Review 3.  Psychiatric and neuroimaging findings in Creutzfeldt-Jakob disease.

Authors:  Jennifer L Martindale; Michael D Geschwind; Bruce L Miller
Journal:  Curr Psychiatry Rep       Date:  2003-05       Impact factor: 5.285

4.  Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets.

Authors:  J Bieschke; A Giese; W Schulz-Schaeffer; I Zerr; S Poser; M Eigen; H Kretzschmar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 5.  Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target.

Authors:  Brandon B Holmes; Marc I Diamond
Journal:  J Biol Chem       Date:  2014-05-23       Impact factor: 5.157

6.  Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion disease.

Authors:  M Diez; J Koistinaho; S J Dearmond; D Groth; S B Prusiner; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

Review 7.  Implications of peptide assemblies in amyloid diseases.

Authors:  Pu Chun Ke; Marc-Antonie Sani; Feng Ding; Aleksandr Kakinen; Ibrahim Javed; Frances Separovic; Thomas P Davis; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

Review 8.  Inherited prion diseases.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

9.  Overexpression of PLK3 Mediates the Degradation of Abnormal Prion Proteins Dependent on Chaperone-Mediated Autophagy.

Authors:  Hui Wang; Chan Tian; Jing Sun; Li-Na Chen; Yan Lv; Xiao-Dong Yang; Kang Xiao; Jing Wang; Cao Chen; Qi Shi; Qi-Xiang Shao; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2016-06-25       Impact factor: 5.590

Review 10.  Neurodegeneration in humans caused by prions.

Authors:  S B Prusiner
Journal:  West J Med       Date:  1994-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.